Ukrainian Pharma Companies Reportedly Leaving Country Amid Specialist Shortage
L'essentiel
- Ukrainian pharmaceutical companies are reportedly exiting the country due to a severe shortage of specialists and labor.
- Biopharma plans to open an €85 million production facility in Romania by late 2027.
Résumé généré par IA
Pourquoi c'est important
Ukrainian pharmaceutical companies are reportedly leaving the country due to a shortage of specialists and labor. Biopharma is planning to launch a new production facility in Romania.
MOSCOW, June 23. /TASS/. Ukrainian pharmaceutical companies are leaving the country due to a shortage of specialists, a source in the Russian law enforcement agencies told TASS.
"The remnants of Ukrainian pharmaceuticals are leaving Ukraine. The decision of the Ukrainian 'businessmen' is primarily due to the catastrophic shortage of not only specialists in Ukraine, but also of ordinary labor," the source said.
According to the source, the Ukrainian biotechnology company Biopharma intends to launch an 85 million euro production facility in Arad, Romania by the end of 2027. Construction has already been completed, and all engineering networks are to be connected by September 1.
À surveiller
Perspective IA — des possibilités, pas des certitudes
Biopharma to launch Romanian facility by end of 2027.
Très probable · En quelques années
Questions ouvertes
- What is the scale of the specialist shortage?
- What specific factors contribute to the labor shortage?
- Will other Ukrainian pharma companies follow suit?
